Federal Register / Vol. 82, No. 178 / Friday, September 15, 2017 / Notices 43369 

or confidential information. In 

particular, your comment should not 

include any sensitive personal 

information, such as your or anyone 

else’s Social Security number; date of 

birth; driver’s license number or other 

state identification number, or foreign 

country equivalent; passport number; 

financial account number; or credit or 

debit card number. You are also solely 

responsible for making sure that your 

comment does not include any sensitive 

health information, such as medical 

records or other individually 

identifiable health information. In 

addition, your comment should not 

include any ‘‘trade secret or any 

commercial or financial information 

which . . . is privileged or 

confidential’’—as provided by Section 

6(f) of the FTC Act, 15 U.S.C. 46(f), and 

FTC Rule 4.10(a)(2), 16 CFR 4.10(a)(2)— 

including in particular competitively 

sensitive information such as costs, 

sales statistics, inventories, formulas, 

patterns, devices, manufacturing 

processes, or customer names. 

Comments containing material for 

which confidential treatment is 

requested must be filed in paper form, 

must be clearly labeled ‘‘Confidential,’’ 

and must comply with FTC Rule 4.9(c). 

In particular, the written request for 

confidential treatment that accompanies 

the comment must include the factual 

and legal basis for the request, and must 

identify the specific portions of the 

comment to be withheld from the public 

record. See FTC Rule 4.9(c). Your 

comment will be kept confidential only 

if the General Counsel grants your 

request in accordance with the law and 

the public interest. Once your comment 

has been posted on the public FTC Web 

site—as legally required by FTC Rule 

4.9(b)—we cannot redact or remove 

your comment from the FTC Web site, 

unless you submit a confidentiality 

request that meets the requirements for 

such treatment under FTC Rule 4.9(c), 

and the General Counsel grants that 

request. 

Visit the FTC Web site at http://

www.ftc.gov to read this Notice and the 

news release describing it. The FTC Act 

and other laws that the Commission 

administers permit the collection of 

public comments to consider and use in 

this proceeding, as appropriate. The 

Commission will consider all timely 

and responsive public comments that it 

receives on or before October 10, 2017. 

For information on the Commission’s 

privacy policy, including routine uses 

permitted by the Privacy Act, see 

https://www.ftc.gov/site-information/ 

privacy-policy. 

Analysis of Proposed Consent Order To 

Aid Public Comment 

The Federal Trade Commission 

(‘‘FTC’’ or ‘‘Commission’’) has accepted, 

subject to final approval, a consent 

agreement applicable to Md7, LLC 

(‘‘Md7’’). 

The proposed consent order has been 

placed on the public record for thirty 

(30) days for receipt of comments by 

interested persons. Comments received 

during this period will become part of 

the public record. After thirty days, the 

Commission will again review the 

agreement and the comments received, 

and will decide whether it should 

withdraw from the agreement and take 

appropriate action or make final the 

agreement’s proposed order. 

This matter concerns alleged false or 

misleading representations that Md7 

made to consumers concerning its 

participation in the EU-U.S. Privacy 

Shield framework agreed upon by the 

U.S. and the European Union (‘‘EU’’). 

The EU-U.S. Privacy Shield framework 

allows U.S. companies to transfer data 

outside the EU consistent with EU law. 

To join the EU-U.S. Privacy Shield 

framework, a company must self-certify 

to the U.S. Department of Commerce 

(‘‘Commerce’’) that it complies with a 

set of principles and related 

requirements that have been deemed by 

the European Commission as providing 

‘‘adequate’’ privacy protection. These 

principles include notice; choice; 

accountability for onward transfer; 

security; data integrity and purpose 

limitation; access; and recourse, 

enforcement, and liability. Commerce 

maintains a public Web site, https://

www.privacyshield.gov/list, where it 

posts the names of companies that have 

self-certified to the EU-U.S. Privacy 

Shield framework. The listing of 

companies indicates whether their selfcertification is current. Companies are 

required to re-certify every year in order 

to retain their status as current members 

of the EU-U.S. Privacy Shield 

framework. 

Md7 assists wireless operators in 

managing real estate-related issues. 

According to the Commission’s 

complaint, Md7 has set forth on its Web 

site, www.md7.com/privacy-policy/, 

privacy policies and statements about 

its practices, including statements 

related to its participation in the EUU.S. Privacy Shield framework. 

The Commission’s complaint alleges 

that Md7 falsely represented that it was 

certified to participate in the EU-U.S. 

Privacy Shield framework when, in fact, 

Md7 never completed the necessary 

steps to finalize its application and thus, 

was not certified to participate in the 

EU-U.S. Privacy Shield framework. 

Part I of the proposed order prohibits 

Md7 from making misrepresentations 

about its membership in any privacy or 

security program sponsored by the 

government or any other self-regulatory 

or standard-setting organization, 

including, but not limited to, the EUU.S. Privacy Shield framework. 

Parts II through VI of the proposed 

order are reporting and compliance 

provisions. Part II requires 

acknowledgement of the order and 

dissemination of the order now and in 

the future to persons with 

responsibilities relating to the subject 

matter of the order. Part III ensures 

notification to the FTC of changes in 

corporate status and mandates that Md7 

submit an initial compliance report to 

the FTC. Part IV requires Md7 to retain 

documents relating to its compliance 

with the order for a five-year period. 

Part V mandates that Md7 make 

available to the FTC information or 

subsequent compliance reports, as 

requested. Part VI is a provision 

‘‘sunsetting’’ the order after twenty (20) 

years, with certain exceptions. 

The purpose of this analysis is to 

facilitate public comment on the 

proposed order. It is not intended to 

constitute an official interpretation of 

the proposed complaint or order or to 

modify the order’s terms in any way. 

By direction of the Commission. 

Donald S. Clark, 

Secretary. 

[FR Doc. 2017–19618 Filed 9–14–17; 8:45 am] 

BILLING CODE 6750–01–P 

FEDERAL TRADE COMMISSION 

[File No. 172 3173] 

Decusoft, LLC; Analysis To Aid Public 

Comment 

AGENCY: Federal Trade Commission. 

ACTION: Proposed consent agreement. 

SUMMARY: The consent agreement in this 

matter settles alleged violations of 

federal law prohibiting unfair or 

deceptive acts or practices. The attached 

Analysis to Aid Public Comment 

describes both the allegations in the 

complaint and the terms of the consent 

order—embodied in the consent 

agreement—that would settle these 

allegations. 

DATES: Comments must be received on 

or before October 10, 2017. 

ADDRESSES: Interested parties may file a 

comment online or on paper, by 

following the instructions in the 

Request for Comment part of the 

mstockstill on DSK30JT082PROD with NOTICES

43370 Federal Register / Vol. 82, No. 178 / Friday, September 15, 2017 / Notices 

SUPPLEMENTARY INFORMATION section 

below. Write: ‘‘In the Matter of Decusoft, 

LLC, File No. 172 3173’’ on your 

comment, and file your comment online 

at https://ftcpublic.commentworks.com/ 

ftc/decusoftconsent by following the 

instructions on the web-based form. If 

you prefer to file your comment on 

paper, write ‘‘In the Matter of Decusoft, 

LLC, File No. 172 3173’’ on your 

comment and on the envelope, and mail 

your comment to the following address: 

Federal Trade Commission, Office of the 

Secretary, 600 Pennsylvania Avenue 

NW., Suite CC–5610 (Annex D), 

Washington, DC 20580, or deliver your 

comment to the following address: 

Federal Trade Commission, Office of the 

Secretary, Constitution Center, 400 7th 

Street SW., 5th Floor, Suite 5610 

(Annex D), Washington, DC 20024. 

FOR FURTHER INFORMATION CONTACT: 

Monique Einhorn (202–326–2575), 

Bureau of Consumer Protection, 600 

Pennsylvania Avenue NW., Washington, 

DC 20580. 

SUPPLEMENTARY INFORMATION: Pursuant 

to Section 6(f) of the Federal Trade 

Commission Act, 15 U.S.C. 46(f), and 

FTC Rule 2.34, 16 CFR 2.34, notice is 

hereby given that the above-captioned 

consent agreement containing a consent 

order to cease and desist, having been 

filed with and accepted, subject to final 

approval, by the Commission, has been 

placed on the public record for a period 

of thirty (30) days. The following 

Analysis to Aid Public Comment 

describes the terms of the consent 

agreement, and the allegations in the 

complaint. An electronic copy of the 

full text of the consent agreement 

package can be obtained from the FTC 

Home Page (for September 8, 2017), on 

the World Wide Web, at https://

www.ftc.gov/news-events/commissionactions. 

You can file a comment online or on 

paper. For the Commission to consider 

your comment, we must receive it on or 

before October 10, 2017. Write ‘‘In the 

Matter of Decusoft, LLC, File No. 172 

3173’’ on your comment. Your 

comment—including your name and 

your state—will be placed on the public 

record of this proceeding, including, to 

the extent practicable, on the public 

Commission Web site, at https://

www.ftc.gov/policy/public-comments. 

Postal mail addressed to the 

Commission is subject to delay due to 

heightened security screening. As a 

result, we encourage you to submit your 

comments online. To make sure that the 

Commission considers your online 

comment, you must file it at https://

ftcpublic.commentworks.com/ftc/ 

decusoftconsent by following the 

instructions on the web-based form. If 

this Notice appears at http://

www.regulations.gov/#!home, you also 

may file a comment through that Web 

site. 

If you prefer to file your comment on 

paper, write ‘‘In the Matter of Decusoft, 

LLC, File No. 172 3173’’ on your 

comment and on the envelope, and mail 

your comment to the following address: 

Federal Trade Commission, Office of the 

Secretary, 600 Pennsylvania Avenue 

NW., Suite CC–5610 (Annex D), 

Washington, DC 20580, or deliver your 

comment to the following address: 

Federal Trade Commission, Office of the 

Secretary, Constitution Center, 400 7th 

Street SW., 5th Floor, Suite 5610 

(Annex D), Washington, DC 20024. If 

possible, submit your paper comment to 

the Commission by courier or overnight 

service. 

Because your comment will be placed 

on the publicly accessible FTC Web site 

at https://www.ftc.gov, you are solely 

responsible for making sure that your 

comment does not include any sensitive 

or confidential information. In 

particular, your comment should not 

include any sensitive personal 

information, such as your or anyone 

else’s Social Security number; date of 

birth; driver’s license number or other 

state identification number, or foreign 

country equivalent; passport number; 

financial account number; or credit or 

debit card number. You are also solely 

responsible for making sure that your 

comment does not include any sensitive 

health information, such as medical 

records or other individually 

identifiable health information. In 

addition, your comment should not 

include any ‘‘trade secret or any 

commercial or financial information 

which . . . is privileged or 

confidential’’—as provided by Section 

6(f) of the FTC Act, 15 U.S.C. 46(f), and 

FTC Rule 4.10(a)(2), 16 CFR 4.10(a)(2)— 

including in particular competitively 

sensitive information such as costs, 

sales statistics, inventories, formulas, 

patterns, devices, manufacturing 

processes, or customer names. 

Comments containing material for 

which confidential treatment is 

requested must be filed in paper form, 

must be clearly labeled ‘‘Confidential,’’ 

and must comply with FTC Rule 4.9(c). 

In particular, the written request for 

confidential treatment that accompanies 

the comment must include the factual 

and legal basis for the request, and must 

identify the specific portions of the 

comment to be withheld from the public 

record. See FTC Rule 4.9(c). Your 

comment will be kept confidential only 

if the General Counsel grants your 

request in accordance with the law and 

the public interest. Once your comment 

has been posted on the public FTC Web 

site—as legally required by FTC Rule 

4.9(b)—we cannot redact or remove 

your comment from the FTC Web site, 

unless you submit a confidentiality 

request that meets the requirements for 

such treatment under FTC Rule 4.9(c), 

and the General Counsel grants that 

request. 

Visit the FTC Web site at http://

www.ftc.gov to read this Notice and the 

news release describing it. The FTC Act 

and other laws that the Commission 

administers permit the collection of 

public comments to consider and use in 

this proceeding, as appropriate. The 

Commission will consider all timely 

and responsive public comments that it 

receives on or before October 10, 2017. 

For information on the Commission’s 

privacy policy, including routine uses 

permitted by the Privacy Act, see 

https://www.ftc.gov/site-information/ 

privacy-policy. 

Analysis of Proposed Consent Order To 

Aid Public Comment 

The Federal Trade Commission 

(‘‘FTC’’ or ‘‘Commission’’) has accepted, 

subject to final approval, a consent 

agreement applicable to Decusoft, LLC 

(‘‘Decusoft’’). 

The proposed consent order has been 

placed on the public record for thirty 

(30) days for receipt of comments by 

interested persons. Comments received 

during this period will become part of 

the public record. After thirty days, the 

Commission will again review the 

agreement and the comments received, 

and will decide whether it should 

withdraw from the agreement and take 

appropriate action or make final the 

agreement’s proposed order. 

This matter concerns alleged false or 

misleading representations that 

Decusoft made to consumers concerning 

its participation in the Privacy Shield 

frameworks agreed upon by the U.S. and 

the European Union (‘‘EU’’) and the U.S. 

and Switzerland (collectively, ‘‘Privacy 

Shield frameworks’’). The Privacy 

Shield frameworks allow U.S. 

companies to transfer data outside the 

EU and Switzerland consistent with EU 

and Swiss law. To join the Privacy 

Shield frameworks, a company must 

self-certify to the U.S. Department of 

Commerce (‘‘Commerce’’) that it 

complies with a set of principles and 

related requirements that have been 

deemed by the European Commission 

and Switzerland as providing 

‘‘adequate’’ privacy protection. These 

principles include notice; choice; 

accountability for onward transfer; 

security; data integrity and purpose 

limitation; access; and recourse, 

mstockstill on DSK30JT082PROD with NOTICES

Federal Register / Vol. 82, No. 178 / Friday, September 15, 2017 / Notices 43371 

enforcement, and liability. Commerce 

maintains a public Web site, https://

www.privacyshield.gov/list, where it 

posts the names of companies that have 

self-certified to the Privacy Shield 

frameworks. The listing of companies 

indicates whether their self-certification 

is current. Companies are required to recertify every year in order to retain their 

status as current members of the Privacy 

Shield frameworks. 

Decusoft develops software for use in 

human resources applications. 

According to the Commission’s 

complaint, Decusoft has set forth on its 

Web site, www.decusoft.com/privacypolicy, privacy policies and statements 

about its practices, including statements 

related to its participation in the EUU.S. and the Swiss-U.S. Privacy Shield 

frameworks. 

The Commission’s complaint alleges 

that Decusoft falsely represented that it 

was certified to participate in the 

Privacy Shield frameworks when, in 

fact, Decusoft never completed the 

necessary steps to finalize its 

applications, and thus, was not certified 

to participate in either the EU-U.S. 

Privacy Shield framework or the SwissU.S. Privacy Shield framework. 

Part I of the proposed order prohibits 

Decusoft from making 

misrepresentations about its 

membership in any privacy or security 

program sponsored by the government 

or any other self-regulatory or standardsetting organization, including, but not 

limited to, the EU-U.S. Privacy Shield 

framework and the Swiss-U.S. Safe 

Privacy Shield framework. 

Parts II through VI of the proposed 

order are reporting and compliance 

provisions. Part II requires 

acknowledgement of the order and 

dissemination of the order now and in 

the future to persons with 

responsibilities relating to the subject 

matter of the order. Part III ensures 

notification to the FTC of changes in 

corporate status and mandates that 

Decusoft submit an initial compliance 

report to the FTC. Part IV requires 

Decusoft to retain documents relating to 

its compliance with the order for a fiveyear period. 

Part V mandates that Decusoft make 

available to the FTC information or 

subsequent compliance reports, as 

requested. Part VI is a provision 

‘‘sunsetting’’ the order after twenty (20) 

years, with certain exceptions. 

The purpose of this analysis is to 

facilitate public comment on the 

proposed order. It is not intended to 

constitute an official interpretation of 

the proposed complaint or order or to 

modify the order’s terms in any way. 

By direction of the Commission. 

Donald S. Clark, 

Secretary. 

[FR Doc. 2017–19617 Filed 9–14–17; 8:45 am] 

BILLING CODE 6750–01–P 

FEDERAL TRADE COMMISSION 

Granting of Requests for Early 

Termination of the Waiting Period 

Under the Premerger Notification 

Rules 

Section 7A of the Clayton Act, 15 

U.S.C. 18a, as added by Title II of the 

Hart-Scott-Rodino Antitrust 

Improvements Act of 1976, requires 

persons contemplating certain mergers 

or acquisitions to give the Federal Trade 

Commission and the Assistant Attorney 

General advance notice and to wait 

designated periods before 

consummation of such plans. Section 

7A(b)(2) of the Act permits the agencies, 

in individual cases, to terminate this 

waiting period prior to its expiration 

and requires that notice of this action be 

published in the Federal Register. 

The following transactions were 

granted early termination—on the dates 

indicated—of the waiting period 

provided by law and the premerger 

notification rules. The listing for each 

transaction includes the transaction 

number and the parties to the 

transaction. The grants were made by 

the Federal Trade Commission and the 

Assistant Attorney General for the 

Antitrust Division of the Department of 

Justice. Neither agency intends to take 

any action with respect to these 

proposed acquisitions during the 

applicable waiting period.

EARLY TERMINATIONS GRANTED

[August 1, 2017 through August 31, 2017] 

08/01/2017 

20171618 ...... G New Mountain Partners IV, L.P.; Larsen MacColl Partners, L.P.; New Mountain Partners IV, L.P. 

08/02/2017 

20171591 ...... G Michael Ashley; The Finish Line, Inc.; Michael Ashley. 

08/03/2017 

20171584 ...... G Stanley G. Middleman; New York Community Bancorp, Inc.; Stanley G. Middleman. 

08/04/2017 

20171603 ...... G ABM Industries Incorporated; GCA Holding Corp.; ABM Industries Incorporated. 

20171631 ...... G Cincinnati Bell Inc.; Marlin Equity III, L.P.; Cincinnati Bell Inc. 

08/07/2017 

20171626 ...... G OZ Overseas Fund II, Ltd.; EQT Corporation; OZ Overseas Fund II, Ltd. 

20171641 ...... G ArcLight Energy Partners Fund VI, L.P.; Halcon Resources Corporation; ArcLight Energy Partners Fund VI, L.P. 

20171649 ...... G Golden Gate Capital Opportunity Fund, L.P.; Summit Park II, L.P.; Golden Gate Capital Opportunity Fund, L.P. 

20171652 ...... G EQT Infrastructure III (No. 1) SCSp; Jacques R. and Naila Saade; EQT Infrastructure III (No. 1) SCSp. 

20171656 ...... G Michael Gregory O’Hara; Alexandre Chemla; Michael Gregory O’Hara. 

20171657 ...... G Magellan Health, Inc.; TA XI L.P.; Magellan Health, Inc. 

20171662 ...... G China Regenerative Medicine International Limited; Valeant Pharmaceuticals International, Inc.; China Regenerative Medicine International Limited. 

20171666 ...... G AI Fresh Parent, Inc.; FS Equity Partners VI, L.P.; AI Fresh Parent, Inc. 

20171670 ...... G DENSO Corporation; Fujitsu Limited; DENSO Corporation. 

20171675 ...... G Blackstone Capital Partners VII L.P.; Providence Equity Partners VII–A L.P.; Blackstone Capital Partners VII L.P. 

20171679 ...... G Konica Minolta, Inc.; Ambry Genetics Corporation; Konica Minolta, Inc. 

mstockstill on DSK30JT082PROD with NOTICES